Jorey Chernett Exits Position in IO Biotech, Inc. (IOBT) via Schedule 13G/A

Jorey Chernett filed an Amendment No. 2 to Schedule 13G on May 20, 2026, regarding holdings in IO Biotech, Inc. (IOBT). This filing serves as an exit statement for the reporting person. As of the close of business on May 19, 2026, Jorey Chernett reported owning zero shares of the Issuer's common stock, par value $0.001 per share. This represents a complete liquidation of their previous position, resulting in 0.0% ownership. The reporting person's principal business address is located in Bloomfield Hills, Michigan. The filing was made pursuant to Rule 13d-1(c), certifying that the securities were not held for the purpose of changing or influencing the control of the issuer. Consequently, Jorey Chernett no longer maintains a reportable beneficial interest in IO Biotech, Inc. and has ceased to be a 5% beneficial owner.